Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag

Poor graft function (PGF) is a life-threatening complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Current treatment strategies include the use of growth factors, CD34+-selected st...

Source: Journal of Hematology and Oncology - August 16, 2018 Category: Hematology Authors: Cen Tang, Feng Chen, Danqing Kong, Qinfen Ma, Haiping Dai, Jia Yin, Zheng Li, Jia Chen, Xiaming Zhu, Xinliang Mao, Depei Wu and Xiaowen Tang Tags: Letter to the Editor Source Type: research